StreetInsider.com News Articles

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:

SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.

Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:

“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.

In the United States, the transitional effects

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard®

Mon, 13 Apr 2026 12:00:00 -0400

Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments

Transaction supports SpineGuard’s objective or reaching operational breakeven by the end of 2026

MORGANTOWN, W. Va. & BOULDER, Colo. & PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced the completion of the transfer of SpineGuard Inc assets and the execution of an

SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard®

Mon, 13 Apr 2026 12:00:00 -0400

Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments

Transaction supports SpineGuard’s objective or reaching operational breakeven by the end of 2026

MORGANTOWN, W. Va. & BOULDER, Colo. & PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced the completion of the transfer of SpineGuard Inc assets and the execution of an

SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard®

Mon, 13 Apr 2026 12:00:00 -0400

Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments

Transaction supports SpineGuard’s objective or reaching operational breakeven by the end of 2026

MORGANTOWN, W. Va. & BOULDER, Colo. & PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced the completion of the transfer of SpineGuard Inc assets and the execution of an

SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard®

Mon, 13 Apr 2026 12:00:00 -0400

Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments

Transaction supports SpineGuard’s objective or reaching operational breakeven by the end of 2026

MORGANTOWN, W. Va. & BOULDER, Colo. & PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced the completion of the transfer of SpineGuard Inc assets and the execution of an

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing

Wed, 08 Apr 2026 01:00:00 -0400

Operating income improved by 46%

Cash runaway extended to 2Q27

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2025 financial results for the year ended December 31, 2025, as approved by the Board of Directors on April 07, 2026, its first quarter 2026 sales, as well as the completion of a bond financing of up to €1 million.
2025 Financial Results

SpineGuard Announces the Full Settlement of the Norgine and Harbert European Growth Bond Issues

Wed, 25 Mar 2026 13:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible), an innovative company deploying its digital surgical guidance (DSG®) technology—which measures tissue electrical conductivity locally in real time to ensure the safe and simplified placement of bone implants—announced today the full repayment of its bonds issued to Norgine and Harbert European Growth (now Claret Capital Partners).
Anne-Charlotte Millard, Chief Financial Officer of SpineGuard, stated: “The settlement of our principal debt marks a key milestone for SpineGuard. It allows us to proceed with confidence toward finalizing the transfer of our American subsidiary to Omnia Medical, our U.S.